Postmortem Documentation of SARS-CoV-2 in Utero and Postpartum Transmission, through Amniotic Fluid, Placental, and Pulmonary Tissue RT-PCR
Authors:
- Alexandra EnacheAEAlexandra Enache
- Veronica CiocanVCVeronica Ciocan
- Camelia Oana MuresanCMCamelia Oana Muresan
- Talida Georgiana CutTalida Georgiana Cut
- Dorin NovacescuDNDorin Novacescu
- Corina PaulCorina Paul
- Nicoleta AndreescuNANicoleta Andreescu
- Alexandra MihailescuAMAlexandra Mihailescu
- Marius RaicaMRMarius Raica
- Raluca DumacheRaluca Dumache
Open Access
- 13 October 2021
- journal article
- research article
- Published by MDPI AG in Applied Sciences
- Vol. 11 (20) , 9505
Abstract
The physiopathology of SARS-CoV-2 infection, during pregnancy and in early childhood, is poorly understood. Unfavorable maternal outcomes, the risk of vertical/postpartum transmission, and severe, multisystem involvement in infants and children highlight the importance of developing a cohesive treatment and nuanced prophylaxis strategy. In this study, we evaluate autopsy reports, pathological findings, and SARS-CoV-2 genome expression in three distinct clinical scenarios: maternal death due to severe COVID-19 with in utero fetal demise (27 weeks); mother with moderate COVID-19 and in utero fetal demise (29 weeks); and 2-month-old infant death with confirmed COVID-19 caregivers. We report the presence of the SARS-CoV-2 genome in amniotic fluid and placental tissue in the context of in utero transmission of SARS-CoV-2, but also in postmortem infant pulmonary tissue samples in a case of late postpartum SARS-CoV-2 transmission with asymptomatic, rapidly progressive disease, resulting in infant death. Key pathological findings offer a descriptive portrayal of maternal, in utero, and infantile COVID-19 pathogenesis. Further investigations are necessary to fully comprehend the clinical implications of SARS-CoV-2 infection during pregnancy, a prerequisite for adequate therapeutic management and harm reduction.Keywords
This publication has 135 references indexed in Scilit:
- A Transmembrane Serine Protease Is Linked to the Severe Acute Respiratory Syndrome Coronavirus Receptor and Activates Virus EntryJournal of Virology, 2011
- REVIEW ARTICLE: The Immune System in Pregnancy: A Unique ComplexityAmerican Journal of Reproductive Immunology, 2010
- H1N1 2009 influenza virus infection during pregnancy in the USAThe Lancet, 2009
- Coronaviruses post-SARS: update on replication and pathogenesisNature Reviews Microbiology, 2009
- ACE2 expression and activity are enhanced during pregnancyAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2008
- Distribution of Angiotensin-(1-7) and ACE2 in Human Placentas of Normal and Pathological PregnanciesPlacenta, 2006
- ACE2 Receptor Expression and Severe Acute Respiratory Syndrome Coronavirus Infection Depend on Differentiation of Human Airway EpitheliaJournal of Virology, 2005
- A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injuryNature Medicine, 2005
- Labor Increases Maternal DNA Contamination in Cord BloodClinical Chemistry, 2004
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004